Similar Articles

Different Guillain-Barré Syndrome Variants Associated with COVID-19: Report of 4 Clinical Cases

Zeynep Ünlütürk, Çağatay Hilmi Öncel, Barış Haytı, Çağdaş Erdoğan

DOI: 10.4274/tnd.2021.86094

Issue: 2022, Volume 28 - Issue 1
142 171

Factors Associated with Prognosis in Patients with Guillain-Barré Syndrome

Mustafa Çetiner, Murat Seyit, Gönül Akdağ, Hayri Demirbaş, Özge Temel, Sibel Canbaz Kabay

DOI: 10.4274/tnd.2019.34445

Issue: 2019, Volume 25 - Issue 3
0 138

Differential Diagnosis Approach to Bilateral Peripheral Facial Paralysis: A Case Report

Nihan Hande Akçakaya, Meltem Hale Alpsan Gökmen, Yeşim Gülşen Parman, Feza Deymeer, Piraye Oflazer

DOI: 10.4274/tnd.02212

Issue: 2016, Volume 22 - Issue 4
0 141

A Rare Guillain Barre Syndrome Variant: Facial Diplegia Paresthesia

Emel Oguz Akarsu, Destina Yalçın, Reyhan Sürmeli, Ahmet Demir, Gülin Sünter, Yunus Diler

DOI: 10.4274/tnd.70456

Issue: 2015, Volume 21 - Issue 4
0 129

lntravenous lmmunoglobulin In Guillain-Barre Syndrome

Sibel K. VELİOĞLU, Cavit BOZ, Mehmet ÖZMENOĞLU

Issue: 2001, Volume 7 - Issue 1
0 78

Immunoglobulin Treatment and Electrophysiological Findings in -Guillain-Barrè Syndrome

Münevver ÇELİK, Buket OFLAZOĞLU, Hulki FORTA

Issue: 1997, Volume 3 - Issue 1-2
0 100

Guillain-Barré Syndrome with Bilateral Peripheral Facial Nerve Paralysis After COVID-19 Infection

Özgül Ocak

DOI: 10.4274/tnd.2021.78095

Issue: 2021, Volume 27 - Supplement 1
0 201

Guillain-Barré Syndrome and COVID-19 Vaccines: A Comment

Joob Beuy, Viroj Wiwanitkit

DOI: 10.4274/tnd.2021.47048

Issue: 2021, Volume 27 - Supplement 1
0 136